Further processing options
Romidepsin (FK228) regulates the expression of the immune checkpoint ligand PD-L1 and exerts synergistic anti-tumour activity with an anti-PD-1 antibody in colon cancer
Saved in:
Journal Title: | Annals of Oncology |
---|---|
Authors and Corporations: | |
In: | Annals of Oncology, 30, 2019, p. v230 |
Type of Resource: | E-Article |
Language: | English |
published: |
Elsevier BV
|
Subjects: |